4 Contradicted by research
There are no stem cell treatments that have been rigorously tested in controlled, blinded human clinical trials.
"And what you mentioned earlier with stem cells, there are no such treatments that have been tested rigorously." (said at 1:01:39)
The claim that no stem cell treatments have been rigorously tested in controlled, blinded human clinical trials is contradicted by the published scientific record. Numerous randomized, double-blind, placebo-controlled human trials have evaluated stem cell interventions across a variety of conditions, including progressive multiple sclerosis, osteoarthritis, traumatic spinal cord injury, and respiratory diseases.
- contradicts: Intra-articular allogeneic adipose-derived mesenchymal stromal cell injections for stage I… (Stem cells translational medicine 2026)
"In this single-site, randomized, double-blind, placebo-controlled trial, patients were assigned to receive either 2 doses of allogeneic expanded ADMSCs, administered 2 weeks apart (Arm A, mean total dose: 69.58 × 106 ADMSCs), or 2 equal-volume normal saline injections (Arm B)." (abstract, methods, passage verified)
pubmedfull study (doi) - contradicts: Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double… (Neurology 2026) · cited 3x in the literature
"In this randomized, double-blind, placebo-controlled phase I/II trial (NCT04749667), patients with progressive MS enrolled at 4 Norwegian tertiary hospitals received a single intrathecal injection of autologous bone marrow-derived MSCs (1 × 10 6 cells/kg) in a crossover design." (abstract, methods, passage verified)
pubmedfull study (doi)
There are no clinical trials in humans showing a clear lifespan or health benefit from fasting.
"there's no clinical studies that show a clear benefit of of fasting in humans." (said at 1:14:15)
The speaker's assertion that there are no clinical studies showing a clear benefit of fasting in humans is contradicted by extensive evidence from randomized controlled trials (RCTs). Numerous systematic reviews, network meta-analyses, and umbrella reviews encompassing dozens of RCTs demonstrate that intermittent fasting regimens produce significant health benefits in humans. These include reductions in body weight, fat mass, waist circumference, fasting insulin, insulin resistance, triglycerides, LDL cholesterol, and blood pressure compared to baseline or non-intervention diets (with effects generally comparable to continuous caloric restriction). While clinical trials evaluating direct lifespan or all-cause mortality endpoints in humans do not exist due to the infeasibility of multi-decade lifespan trials, the claim that human clinical studies show no clear health benefit is false.
- contradicts: Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analy… (JAMA network open 2021) · cited 288x in the literature
"In this umbrella review, we found beneficial associations of IF with anthropometric and cardiometabolic outcomes supported by moderate to high quality of evidence, which supports the role of IF, especially modified alternate-day fasting, as a weight loss approach for adults with overweight or obesity." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Intermittent fasting and health outcomes: an umbrella review of systematic reviews and met… (EClinicalMedicine 2024) · cited 89x in the literature
"A total of 351 associations from 23 meta-analyses with 34 health outcomes were included in the study. ... The summary effects estimates were significant at p < 0.05 in 103 associations, of which 10 (10%) were supported by high certainty of evidence according to GRADE. Specifically, compared with non-intervention diet in adults with overweight or obesity, IF reduced waist circumference (WC) (MD = -1.02 cm; 95% CI: -1.99 to -0.06; p = 0.038), fat mass (MD = -0.72 kg; 95% CI: -1.32 to -0.12; p = 0.019), fasting insulin (SMD = -0.21; 95% CI: -0.40 to -0.02; p = 0.030), low-density lipoprotein cholesterol (LDL-C) (SMD = -0.20; 95% CI: -0.38 to -0.02; p = 0.027), total cholesterol (TC) (SMD = -0.29; 95% CI: -0.48 to -0.10; p = 0.003), and triacylglycerols (TG) (SMD = -0.23; 95% CI: -0.39 to -0.06; p = 0.007)" (abstract, results)
pubmedfull study (doi) - contradicts: Intermittent fasting strategies and their effects on body weight and other cardiometabolic… (BMJ (Clinical research ed.) 2025) · cited 52x in the literature
"99 randomised clinical trials involving 6582 adults of varying health conditions (720 healthy, 5862 existing health conditions) were identified. All intermittent fasting and continuous energy restriction diet strategies reduced body weight when compared with ad-libitum diet." (abstract, results, passage verified)
pubmedfull study (doi)
Athletes who engage in fast-twitch explosive sports such as pole vaulting, gymnastics, high jumping, and sprinting live 5 to 8 years longer on average compared to age-matched cohorts.
"a recent study showed that um it's the pole vaulters, not going to get into that, and the gymnasts, and I think the high jumpers, and the sprinters, so the fast-twitch muscle folks that they get a substantial longevity effect, you know, 5 to 8 years on average, more than their, you know, age-matched cohorts, even compared to other high highly trained athletes." (said at 1:24:57)
The host claims that fast-twitch/explosive power athletes (e.g., sprinters, jumpers, gymnasts, pole vaulters) gain a unique 5- to 8-year longevity advantage, even compared to other elite athletes. While elite athletes as a whole live approximately 4 to 8 years longer than the general population (e.g., 6.5 years on average in Olympic cohorts), systematic reviews and meta-analyses consistently show the opposite discipline pattern: endurance and mixed-aerobic athletes demonstrate the largest and most consistent survival advantages, whereas power/anaerobic athletes exhibit the smallest longevity gains or no statistically significant mortality reduction compared to the general population.
Switzerland has the highest per capita caffeine intake in the world.
"The Swiss also as I recall from something in the Economist a few years ago when I used to I no longer subscribe to them, but the highest caffeine intake in the world is the Swiss." (said at 1:36:20)
Data from national dietary surveys and international dietary comparisons contradict the claim that Switzerland has the highest caffeine intake in the world. In the representative Swiss National Nutrition Survey menuCH (PMID: 31877632), the mean daily caffeine intake among Swiss adults was 191 mg/day, with the authors noting that intake in the Swiss population is similar to neighbouring countries and well below high-consumption countries (such as Scandinavian nations, where mean caffeine consumption from coffee and other sources typically exceeds 300-400 mg/day).
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.